Richard J Kraus

Title: Richard J Kraus: Innovator in Breast Cancer Research

Introduction

Richard J Kraus is a notable inventor based in McFarland, Wisconsin. He has made significant contributions to the field of breast cancer research through his innovative patent. His work focuses on the use of estrogen-related receptor alpha (ERRα) as a biomarker for breast cancer prognosis and treatment strategies.

Latest Patents

Richard J Kraus holds a patent titled "Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer." This invention highlights the importance of ERRα as a breast cancer biomarker, indicating that a high level of ERRα correlates with poor prognosis. By analyzing ERRα expression levels alongside the status of ERα and ErbB2, patients can make informed treatment choices. Additionally, the patent suggests that breast cancer can be treated by modulating ERRα activity.

Career Highlights

Kraus is associated with the Wisconsin Alumni Research Foundation, where he continues to advance research in breast cancer treatment. His work has the potential to significantly impact clinical practices and improve patient outcomes.

Collaborations

Richard J Kraus has collaborated with esteemed colleagues such as Janet E Mertz and Stephen D Johnston, contributing to a collaborative environment that fosters innovation in cancer research.

Conclusion

Richard J Kraus is a pioneering inventor whose work in breast cancer research is paving the way for new treatment strategies. His patent on ERRα as a biomarker and therapeutic target exemplifies the critical intersection of innovation and healthcare.